Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O HUGHES

Showing results (431-440 of 449) with videos related to

Pageof 45
Sort By:
Nature|August 2, 2019
A clinically applicable approach to continuous prediction of future acute kidney injuryNenad Tomašev, Xavier Glorot, Jack W Rae, et al.
Plos Genetics|July 11, 2014
Clonal architecture of secondary acute myeloid leukemia defined by single-cell sequencingAndrew E O Hughes, Vincent Magrini, Ryan Demeter, et al.
Molecular Cell|March 25, 2022
Structural basis of SARM1 activation, substrate recognition, and inhibition by small moleculesYun Shi, Philip S Kerry, Jeffrey D Nanson, et al.
Neuron|March 3, 2021
SARM1 is a metabolic sensor activated by an increased NMN/NAD<sup>+</sup> ratio to trigger axon degenerationMatthew D Figley, Weixi Gu, Jeffrey D Nanson, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2011
Discovery of INCB10820/PF-4178903, a potent, selective, and orally bioavailable dual CCR2 and CCR5 antagonistChangsheng Zheng, Ganfeng Cao, Michael Xia, et al.
Journal of Lipid Research|June 29, 2026
Interleukin-6 stimulates platelet 12-lipoxygenase to drive coagulation in inflammatory arthritisDaniela O Costa, Stuart T O Hughes, Robert H Jenkins, et al.
Bioorganic & Medicinal Chemistry Letters|July 28, 2009
Optimization of the aminopyridopyrazinones class of PDE5 inhibitors: discovery of 3-[(trans-4-hydroxycyclohexyl)amino]-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido[3,4-b]pyrazin-2(1H)-oneRobert O Hughes, John K Walker, D Joseph Rogier, et al.
Frontiers in Oncology|April 24, 2023
Validation of clinical acceptability of deep-learning-based automated segmentation of organs-at-risk for head-and-neck radiotherapy treatment planningJ John Lucido, Todd A DeWees, Todd R Leavitt, et al.
Physical Review Letters|August 29, 2014
Quadrupole collectivity in neutron-rich Fe and Cr isotopesH L Crawford, R M Clark, P Fallon, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of INCB8761/PF-4136309, a Potent, Selective, and Orally Bioavailable CCR2 AntagonistChu-Biao Xue, Anlai Wang, Qi Han, et al.
Pageof 45

Showing results (431-440 of 449) with videos related to

Sort By:
Pageof 45
Nature|August 2, 2019
A clinically applicable approach to continuous prediction of future acute kidney injuryNenad Tomašev, Xavier Glorot, Jack W Rae, et al.
Plos Genetics|July 11, 2014
Clonal architecture of secondary acute myeloid leukemia defined by single-cell sequencingAndrew E O Hughes, Vincent Magrini, Ryan Demeter, et al.
Molecular Cell|March 25, 2022
Structural basis of SARM1 activation, substrate recognition, and inhibition by small moleculesYun Shi, Philip S Kerry, Jeffrey D Nanson, et al.
Neuron|March 3, 2021
SARM1 is a metabolic sensor activated by an increased NMN/NAD<sup>+</sup> ratio to trigger axon degenerationMatthew D Figley, Weixi Gu, Jeffrey D Nanson, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2011
Discovery of INCB10820/PF-4178903, a potent, selective, and orally bioavailable dual CCR2 and CCR5 antagonistChangsheng Zheng, Ganfeng Cao, Michael Xia, et al.
Journal of Lipid Research|June 29, 2026
Interleukin-6 stimulates platelet 12-lipoxygenase to drive coagulation in inflammatory arthritisDaniela O Costa, Stuart T O Hughes, Robert H Jenkins, et al.
Bioorganic & Medicinal Chemistry Letters|July 28, 2009
Optimization of the aminopyridopyrazinones class of PDE5 inhibitors: discovery of 3-[(trans-4-hydroxycyclohexyl)amino]-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido[3,4-b]pyrazin-2(1H)-oneRobert O Hughes, John K Walker, D Joseph Rogier, et al.
Frontiers in Oncology|April 24, 2023
Validation of clinical acceptability of deep-learning-based automated segmentation of organs-at-risk for head-and-neck radiotherapy treatment planningJ John Lucido, Todd A DeWees, Todd R Leavitt, et al.
Physical Review Letters|August 29, 2014
Quadrupole collectivity in neutron-rich Fe and Cr isotopesH L Crawford, R M Clark, P Fallon, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of INCB8761/PF-4136309, a Potent, Selective, and Orally Bioavailable CCR2 AntagonistChu-Biao Xue, Anlai Wang, Qi Han, et al.
Pageof 45